Respi - Anti-asthma Drugs Flashcards
Asthma is characterized by (3)
- Hyper-responsiveness of the airway
- Recurrent reversible airway obstruction
- Chronic airway inflammation
Classes of anti-asthma drugs used & examples
Controllers (anti-inflammatory)
- Inhaled Corticosteroids (Fluticasone, Ciclesonide)
- Leukotriene Receptor Antagonist (Montelukast)
- Cromolyn
- Anti-IgE Antibody (Omalizumab)
Relievers (bronchodilators)
- β2 Agonists (SABA - Salbutamol, LABA - Salmeterol, ULABA - Indacaterol)
- Methylxanthine (Theophylline)
- Anti-Muscarinic (Ipratropium Bromide)
Mechanism of action of inhaled corticosteroids
- Binds to steroid receptors in cell cytoplasm - forms a complex that enters nucleus - binds to glucocorticoid response element (GRE) - controls protein synthesis
- Inhibits enzyme phospholipase A2 (arachidonic acid - inflammation) - Anti-inflammatory effects
- DECREASED T cells, mast cells, macrophages, eosinophils in the airways; shedding of epithelial cells, macrophage phagocytosis & production of cytokines & proteases, COX2, 5-LOX, iNOS & PLA2 expression
- INCREASED lipocortin, β2 receptors on airway smooth muscle
- direct vasoconstriction and decreased plasma exudation/mucus secretion
Uses of inhaled corticosteroids (2)
- 1st line prophylactic Asthma therapy
2. Nocturnal Asthma
Toxicity of inhaled corticosteroids (7)
- Oropharyngeal Candidiasis - immune suppression
- Dysphonia - problem with vocal cords leading to hoarseness
- Cough/Throat Irritation
- Easy bruising of skin (elderly)
- Adrenal Suppression
- Posterior Subcapsular Cataracts
- Osteoporosis
Mechanism of action of leukotriene receptor antagonist
Blocks LTD4 in the leukotriene pathway which contributes to the pathogenesis of asthma (bronchoconstriction, inflammation)
Uses & toxicity of leukotriene receptor antagonists (3+1)
- Prophylaxis & chronic treatment of asthma
- Aspirin-induced asthma
- Exercise-induced asthma
- Eosinophilia
Mechanism of action of cromolyn
- Inhibits mast cell degradation induced by IgE-mediated FcεRI cross linking
- Alters delayed Cl channels - inhibits cellular activation
- Promotes secretion of Annexin A1/Lipocortin-1 - blocks histamine & eicosanoid release from mast cells
- Blocks release of inflammatory mediators from eosinophils, neutrophils, macrophages
Uses of cromolyn (2)
- Prophylactic control of Asthma
- Prophylactic control of Allergic Rhinitis/Conjunctivitis
- prevents cold, dry air & exercise-induced bronchospasm
Toxicity of cromolyn (2)
- Throat irritation, dry mouth, coughing (preventable by first inhaling β2 agonist)
- Unpleasant, bitter taste
Mechanism of action of anti-IgE antibody
- Binds to Fc portion of IgE - decreases FcεRI expression on mast cells/basophils - prevents degranulation & asthmatic reaction
- Depletes free IgE levels in serum
Uses of anti-IgE antibody (2)
- Allergic Asthma
2. Allergic Rhinitis
Mechanism of action of β2 agonists
- Activates β2GPCR - activates adenylyl cyclase - increased cAMP leading to (A) decreased intracellular Ca (B) decreased MLCK (C) increased K+ conductance - leading to airway smooth muscle relaxation
- Mast cell stabilization, reduced microvascular leakiness, increased mucociliary clearance
Uses of β2 agonists (3)
- SABA - reverses constricted airways (PRN)
- LABA - prevents exercise-induced asthma + long term maintenance of (nocturnal) asthma
- ULABA - COPD
Toxicity of β2 agonists (6)
- Fine tremor of skeletal muscle
- Muscle cramps
- Peripheral vasodilation
- Palpitations & tachycardia (cross reaction with β1 receptors)
- Hypokalemia, Hyperglycemia
- Tolerance